.Pharmacolibrary.Drugs.ATC.J.J01DD13

Information

Cefpodoxime is an oral third-generation cephalosporin antibiotic used to treat a variety of bacterial infections, including respiratory tract, skin, urinary tract infections, and gonorrhea. It is approved for use in many countries and remains in clinical use.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers after a single oral dose.

References

1. Linnehan, BK, et al., & Jensen, ED (2024). POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 55(3) 611–619. DOI:10.1638/2023-0139 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39255202

2. Guay, DR (2000). Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin. The Pediatric infectious disease journal 19(12 Suppl) S141–S146. DOI:10.1097/00006454-200012001-00002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11144395

3. Birgy, A, et al., & Bonacorsi, S (2021). Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections. The Journal of antimicrobial chemotherapy 76(11) 2839–2846. DOI:10.1093/jac/dkab289 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34453533

Revisions

• 06/2025 initial generated model